Peptides DB

Research-centric peptide and protocol reference hub

AOD-9604 vs BPC-157

Updated July 21, 2026 · Reviewed by the PeptidesDB Editorial team

AOD-9604: Research use — not FDA-approvedBPC-157: Research use — not FDA-approved

A data-driven comparison of AOD-9604 and BPC-157 (also searched as BPC-157 vs AOD-9604) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

AOD-9604 centers on metabolic, while BPC-157 leans toward healing. On indexed research, BPC-157 is ahead (AOD-9604: 4 studies, Human evidence; BPC-157: 6, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • AOD-9604 is strongest for metabolic; BPC-157 for healing.
  • Evidence: AOD-9604 Human evidence (4 studies) vs BPC-157 Human evidence (6).
  • Both are research-use compounds — not FDA-approved.

Effect profiles, overlaid

HealingMuscleMetabolicNeuroSleepInflammationSkin
AOD-9604BPC-157

At a glance

AOD-9604Human evidence

Modified hGH Fragment | Fat Loss Peptide

Strongest: MetabolicStudies: 4Level: Well Studied
BPC-157Human evidence

Body Protection Compound-157 | Pentadecapeptide

Strongest: HealingStudies: 6Level: Extensively Studied

AOD-9604 vs BPC-157: side-by-side

MetricAOD-9604BPC-157
ClassWeight LossHealing
Regulatory statusResearch use onlyResearch use only
Evidence gradeHuman evidenceHuman evidence
Studies indexed46
Research levelWell StudiedExtensively Studied
Strongest effectMetabolic & appetiteHealing & recovery
Healing & recovery3.04.3
Muscle & body comp0.03.3
Metabolic & appetite4.02.3
Neuro & mood0.03.0
Sleep & circadian0.00.7
Inflammation & immune0.04.0
Skin & aesthetics2.02.0

▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).

Mechanism & pharmacokinetics

PropertyAOD-9604BPC-157
MechanismModified hGH fragment (176–191)Body-protective compound (pentadecapeptide); cytoprotective, pro-angiogenic signaling
RouteSubcutaneous injection (research use)Subcutaneous / oral (research use)

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is AOD-9604?

A GH-fragment–derived peptide primarily discussed for fat loss and body-composition change, sometimes with cartilage and joint-repair context.

Full AOD-9604 profile, mechanism & studies →

What is BPC-157?

Body Protective Compound often discussed for soft-tissue repair, GI support, and inflammation modulation.

Full BPC-157 profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingBPC-1574.3/5 effect signal
MuscleBPC-1573.3/5 effect signal
MetabolicAOD-96044.0/5 effect signal
NeuroBPC-1573.0/5 effect signal
SleepBPC-1570.7/5 effect signal
InflammationBPC-1574.0/5 effect signal
SkinEvenBoth ~2.0/5

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack AOD-9604 and BPC-157?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

AOD-9604 vs BPC-157: side effects

AOD-9604

No community-reported effects logged yet.

BPC-157
  • improved healing28
  • flushing14
  • vivid dreams11
  • nausea3
  • anxiety2

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

AOD-9604 has 4 approved studies indexed (Human evidence), and BPC-157 has 6 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is AOD-9604 or BPC-157 better?

It depends on your goal. AOD-9604 is strongest for metabolic; BPC-157 for healing. BPC-157 has more indexed studies (6). See the goal-by-goal breakdown above.

Is AOD-9604 or BPC-157 better for weight loss?

AOD-9604 shows the stronger metabolic & appetite profile (4.0/5) in community effect data — though weight-loss outcomes depend on the individual and the evidence base.

Is AOD-9604 or BPC-157 better for muscle?

BPC-157 leads on the muscle & body-composition axis (3.3/5).

Which has more research, AOD-9604 or BPC-157?

AOD-9604 has 4 approved studies indexed (Human evidence); BPC-157 has 6 (Human evidence). Higher counts mean more to read, not proven superiority.

Can you stack AOD-9604 and BPC-157?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of AOD-9604 vs BPC-157?

AOD-9604: no community-reported effects logged yet. BPC-157: improved healing, flushing, vivid dreams. These are anonymous reports, not incidence rates — see each profile.

Is AOD-9604 or BPC-157 FDA-approved?

AOD-9604 is a research-use compound and is not FDA-approved. BPC-157 is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is BPC-157 better than AOD-9604?

For healing, BPC-157 has the edge; for metabolic, AOD-9604 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

AOD-9604 and BPC-157 are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 21, 2026.